BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22519279)

  • 1. [Metabolic disorders in patients with psoriasis].
    Sikora-Grabka E; Adamczak M; Wiecek A
    Przegl Lek; 2011; 68(12):1193-8. PubMed ID: 22519279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and the metabolic syndrome.
    Alsufyani MA; Golant AK; Lebwohl M
    Dermatol Ther; 2010; 23(2):137-43. PubMed ID: 20415820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis and metabolic syndrome.
    Takahashi H; Iizuka H
    J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and the metabolic syndrome.
    Gottlieb AB; Dann F; Menter A
    J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis: comorbidities and associations.
    Farley E; Menter A
    G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psoriasis as metabolic and cardiovascular risk factor].
    Tupikowska M; Zdrojowy-Welna A; Maj J
    Pol Merkur Lekarski; 2014 Aug; 37(218):124-7. PubMed ID: 25252450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
    Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
    Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis and cardiovascular disorders.
    Ryan C; Menter A
    G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammation in psoriasis and obesity: implications for therapy.
    Hamminga EA; van der Lely AJ; Neumann HA; Thio HB
    Med Hypotheses; 2006; 67(4):768-73. PubMed ID: 16781085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between psoriasis and the metabolic syndrome. A cross-sectional study.
    Cohen AD; Sherf M; Vidavsky L; Vardy DA; Shapiro J; Meyerovitch J
    Dermatology; 2008; 216(2):152-5. PubMed ID: 18216477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis and its comorbidities.
    Onumah N; Kircik LH
    J Drugs Dermatol; 2012 May; 11(5 Suppl):s5-10. PubMed ID: 22644770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.